Neuropathology of dementia in a large cohort of patients with Parkinson's disease

Parkinsonism and Related Disorders

Volumn 19, Issue 10, 2013, Pages 864-868

  Horvath, Judit ^a   Herrmann, François R ^a   Burkhard, Pierre R ^a   Bouras, Constantin ^a   Kövari, Enikö ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Dementia; Neuropathology; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; TAU PROTEIN;

ALPHA SYNUCLEINOPATHY; AMYLOID NEUROPATHY; AMYLOID PLAQUE; ARTICLE; AUTOPSY; CEREBROVASCULAR DISEASE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DEGENERATION; DEMENTIA; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSON DISEASE; PARKINSON DISEASE DEMENTIA; PRIORITY JOURNAL; SCORING SYSTEM; TAUOPATHY;

DEMENTIA; NEUROPATHOLOGY; PARKINSON'S DISEASE;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; CEREBRAL CORTEX; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; INCLUSION BODIES; LEWY BODIES; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PARKINSON DISEASE; PLAQUE, AMYLOID; SUBSTANTIA NIGRA; SYNUCLEINS; TAU PROTEINS;

EID: 84883284101     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.05.010     Document Type: Article

References (31)

1. Hely M.A., Reid W.G., Adena M.A., Halliday G.M., Morris J.G. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008, 23:837-844.
2. Boller F., Mizutani T., Roessmann U., Gambetti P. Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol 1980, 7:329-335.
3. Hakim A.M., Mathieson G. Dementia in Parkinson disease: a neuropathologic study. Neurology 1979, 29:1209-1214.
4. Gaspar P., Gray F. Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases. Acta Neuropathol 1984, 64:43-52.
5. Kosaka K., Tsuchiya K., Yoshimura M. Lewy body disease with and without dementia: a clinicopathological study of 35 cases. Clin Neuropathol 1988, 7:299-305.
6. Aarsland D., Perry R., Brown A., Larsen J.P., Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol 2005, 58:773-776.
7. Apaydin H., Ahlskog J.E., Parisi J.E., Boeve B.F., Dickson D.W. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 2002, 59:102-112.
8. Harding A.J., Halliday G.M. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 2001, 102:355-363.
9. Hurtig H.I., Trojanowski J.Q., Galvin J., Ewbank D., Schmidt M.L., Lee V.M., et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 2000, 54:1916-1921.
10. Kövari E., Gold G., Herrmann F.R., Canuto A., Hof P.R., Bouras C., et al. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Acta Neuropathol 2003, 106:83-88.
11. Mattila P.M., Rinne J.O., Helenius H., Dickson D.W., Roytta M. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol 2000, 100:285-290.
12. Mattila P.M., Roytta M., Torikka H., Dickson D.W., Rinne J.O. Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease. Acta Neuropathol 1998, 95:576-582.
13. Braak H., Rüb U., Jansen Steur E.N., Del Tredici K., de Vos R.A. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005, 64:1404-1410.
14. Braak H., Del Tredici K., Rüb U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
15. Compta Y., Parkkinen L., O'Sullivan S.S., Vandrovcova J., Holton J.L., Collins C., et al. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?. Brain 2011, 134:1493-1505.
16. Colosimo C., Hughes A.J., Kilford L., Lees A.J. Lewy body cortical involvement may not always predict dementia in Parkinson's disease. JNeurol Neurosurg Psychiatr 2003, 74:852-856.
17. Irwin D.J., White M.T., Toledo J.B., Xie S.X., Robinson J.L., Van Deerlin V., et al. Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 2012, 72:587-598.
18. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996, 47:1113-1124.
19. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991, 82:239-259.
20. Thal D.R., Rüb U., Schultz C., Sassin I., Ghebremedhin E., Del Tredici K., et al. Sequence of Abeta-protein deposition in the human medial temporal lobe. JNeuropathol Exp Neurol 2000, 59:733-748.
21. Kövari E., Gold G., Herrmann F.R., Canuto A., Hof P.R., Michel J.P., et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004, 35:410-414.
22. Jellinger K.A., Attems J. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 2008, 115:427-436.
23. Montine T.J., Phelps C.H., Beach T.G., Bigio E.H., Cairns N.J., Dickson D.W., et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 2012, 123:1-11.
24. Kövari E., Hof P.R., Bouras C. The Geneva brain collection. Ann N Y Acad Sci 2011, 1225(Suppl. 1):E131-E146.
25. Gold G., Giannakopoulos P., Herrmann F.R., Bouras C., Kövari E. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain 2007, 130:2830-2836.
26. Lashley T., Holton J.L., Gray E., Kirkham K., O'Sullivan S.S., Hilbig A., et al. Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients. Acta Neuropathol 2008, 115:417-425.
27. Mandal P.K., Pettegrew J.W., Masliah E., Hamilton R.L., Mandal R. Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease. Neurochem Res 2006, 31:1153-1162.
28. Parkkinen L., Kauppinen T., Pirttila T., Autere J.M., Alafuzoff I. Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 2005, 57:82-91.
29. Pletnikova O., West N., Lee M.K., Rudow G.L., Skolasky R.L., Dawson T.M., et al. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging 2005, 26:1183-1192.
30. Kotzbauer P.T., Cairns N.J., Campbell M.C., Willis A.W., Racette B.A., Tabbal S.D., et al. Pathologic Accumulation of alpha-synuclein and Abeta in Parkinson disease patients with dementia. Arch Neurol 2012, 1-6.
31. Sabbagh M.N., Adler C.H., Lahti T.J., Connor D.J., Vedders L., Peterson L.K., et al. Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord 2009, 23:295-297.